Correlation Between SponsorsOne and CannaPharmaRx
Can any of the company-specific risk be diversified away by investing in both SponsorsOne and CannaPharmaRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SponsorsOne and CannaPharmaRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SponsorsOne and CannaPharmaRx, you can compare the effects of market volatilities on SponsorsOne and CannaPharmaRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SponsorsOne with a short position of CannaPharmaRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of SponsorsOne and CannaPharmaRx.
Diversification Opportunities for SponsorsOne and CannaPharmaRx
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SponsorsOne and CannaPharmaRx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SponsorsOne and CannaPharmaRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CannaPharmaRx and SponsorsOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SponsorsOne are associated (or correlated) with CannaPharmaRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CannaPharmaRx has no effect on the direction of SponsorsOne i.e., SponsorsOne and CannaPharmaRx go up and down completely randomly.
Pair Corralation between SponsorsOne and CannaPharmaRx
If you would invest 0.70 in CannaPharmaRx on September 4, 2024 and sell it today you would earn a total of 0.08 from holding CannaPharmaRx or generate 11.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.41% |
Values | Daily Returns |
SponsorsOne vs. CannaPharmaRx
Performance |
Timeline |
SponsorsOne |
CannaPharmaRx |
SponsorsOne and CannaPharmaRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SponsorsOne and CannaPharmaRx
The main advantage of trading using opposite SponsorsOne and CannaPharmaRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SponsorsOne position performs unexpectedly, CannaPharmaRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CannaPharmaRx will offset losses from the drop in CannaPharmaRx's long position.SponsorsOne vs. Salesforce | SponsorsOne vs. SAP SE ADR | SponsorsOne vs. ServiceNow | SponsorsOne vs. Intuit Inc |
CannaPharmaRx vs. Sky Century Investment | CannaPharmaRx vs. Phibro Animal Health | CannaPharmaRx vs. Curaleaf Holdings | CannaPharmaRx vs. Rimrock Gold Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |